Within-patient variability in immunosuppressive drug exposure is easily identified by measurement of drug concentrations at the outpatient clinic. Fluctuating levels despite a stable drug dose can be observed in a substantial proportion of patients. It has now been shown that this within-patient variability is a predictor for poor long-term outcome after transplantation. Nonadherence most likely is an important determinant of variability, and strategies to tackle nonadherence are being developed.

doi.org/10.1038/ki.2013.484, hdl.handle.net/1765/59329
Kidney International
Department of Pharmacy

van Gelder, T. (2014). Within-patient variability in immunosuppressive drug exposure as a predictor for poor outcome after transplantation. Kidney International (Vol. 85, pp. 1267–1268). doi:10.1038/ki.2013.484